Overview

Pentoxifylline and Lumbar Radiculopathy

Status:
Active, not recruiting

Trial end date:
2021-12-01

Target enrollment:

Participant gender:

Summary

The objective of this prospective controlled crossover study is to evaluate the efficacy and safety of pentoxifylline per os (800 mg daily) in the management of lumbar radiculopathy

Phase:

Phase 4

Details

Lead Sponsor:

St Joseph University, Beirut, Lebanon

Treatments:

Acetaminophen
Ibuprofen
Pentoxifylline
Pregabalin